Moving to the operating highlights for CSL Behring on slide 6. The underlying fundamentals of plasma collection remain strong. Plasma donations continue ... whole pipe. We pay them in accordance ...

CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated as plasma sourcing is a key constraint ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...

CSL) reported a rise in half-year net profit, driven primarily by robust performance in its blood plasma division. The company's CSL Behring unit, which focuses on plasma-derived therapies ...

CSL has reported a 7% net profit rise for the December half, with its blood-derived products offsetting weak flu vaccination ...

Founder Melyn McKay says that by using stablecoins to facilitate donations across borders, Coala Pay can save up to 25% of donation money that would otherwise be eaten up by transaction fees.